2024-05-03 |
2024-05-02 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
2 157
-5.8%
18,91
40 789
USD
|
2 157
-5.8%
|
18,91
|
40 789
USD
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
Donovan Joanne M.
CMO
Dirigeant
|
3 682
-15.6%
18,91
69 627
USD
|
3 682
-15.6%
|
18,91
|
69 627
USD
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
1 956
-37.6%
18,91
36 988
USD
|
1 956
-37.6%
|
18,91
|
36 988
USD
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
1 576
-17.9%
18,91
29 802
USD
|
1 576
-17.9%
|
18,91
|
29 802
USD
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
KOCH KEVIN
President and CEO
Administrateur exécutif
|
3 152
-17.9%
18,91
59 604
USD
|
3 152
-17.9%
|
18,91
|
59 604
USD
|
|
2024-05-03 |
2024-05-02 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
1 718
-11.3%
18,91
32 487
USD
|
1 718
-11.3%
|
18,91
|
32 487
USD
|
|
2024-02-09 |
2024-02-09 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
4 800
-40.6%
20,04
96 209
USD
|
4 800
-40.6%
|
20,04
|
96 209
USD
|
|
2024-02-09 |
2024-02-09 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
8 029
-100.0%
20,01
160 657
USD
|
8 029
-100.0%
|
20,01
|
160 657
USD
|
|
2024-02-09 |
2024-02-08 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
4 600
-39.6%
20,01
92 049
USD
|
4 600
-39.6%
|
20,01
|
92 049
USD
|
|
2024-02-09 |
2024-02-08 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
3 813
-100.0%
20,01
76 285
USD
|
3 813
-100.0%
|
20,01
|
76 285
USD
|
|
2024-02-09 |
2024-02-07 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
600
-7.9%
20,00
12 000
USD
|
600
-7.9%
|
20,00
|
12 000
USD
|
|
2024-02-09 |
2024-02-07 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
17 993
-100.0%
20,00
359 864
USD
|
17 993
-100.0%
|
20,00
|
359 864
USD
|
|
2024-01-25 |
2024-01-23 |
A
Achat
|
Thompson Peter A.
Administrateur non-exécutif
Large shareholder
|
454 545
+3.3%
11,00
4 999 995
USD
|
454 545
+3.3%
|
11,00
|
4 999 995
USD
|
|
2024-01-25 |
2024-01-23 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Large shareholder
|
454 545
+3.3%
11,00
4 999 995
USD
|
454 545
+3.3%
|
11,00
|
4 999 995
USD
|
|
2024-01-25 |
2024-01-23 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
90 000
-75.6%
15,78
1 419 759
USD
|
90 000
-75.6%
|
15,78
|
1 419 759
USD
|
|
2023-12-28 |
2023-12-27 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
8 497
-100.0%
10,50
89 219
USD
|
8 497
-100.0%
|
10,50
|
89 219
USD
|
|
2023-12-28 |
2023-12-26 |
A
Achat
|
Fox Jonathan C
Administrateur non-exécutif
|
10 857
+inf%
9,30
100 958
USD
|
10 857
+inf%
|
9,30
|
100 958
USD
|
|
2023-12-28 |
2023-12-26 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
172 585
-98.0%
9,33
1 610 097
USD
|
172 585
-98.0%
|
9,33
|
1 610 097
USD
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Donovan Joanne M.
CMO
Dirigeant
|
3 254
-24.6%
8,90
28 977
USD
|
3 254
-24.6%
|
8,90
|
28 977
USD
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
1 897
-22.4%
8,90
16 893
USD
|
1 897
-22.4%
|
8,90
|
16 893
USD
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
1 602
-0.9%
8,90
14 266
USD
|
1 602
-0.9%
|
8,90
|
14 266
USD
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Carruthers R Michael
Chief Financial Officer
Dirigeant
|
1 336
-7.7%
8,90
11 897
USD
|
1 336
-7.7%
|
8,90
|
11 897
USD
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
Derakhshan Behrad
Chief Business Officer
Dirigeant
|
1 747
-19.9%
8,90
15 557
USD
|
1 747
-19.9%
|
8,90
|
15 557
USD
|
|
2023-05-03 |
2023-05-02 |
V
Vente
|
KOCH KEVIN
President and CEO
Administrateur exécutif
|
3 203
-30.8%
8,90
28 522
USD
|
3 203
-30.8%
|
8,90
|
28 522
USD
|
|
2022-10-05 |
2022-10-03 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
4 730
-61.2%
9,76
46 155
USD
|
4 730
-61.2%
|
9,76
|
46 155
USD
|
|
2022-09-16 |
2022-09-16 |
A
Achat
|
Thompson Peter A.
Administrateur non-exécutif
Large shareholder
|
484 496
+3.6%
10,32
4 999 999
USD
|
484 496
+3.6%
|
10,32
|
4 999 999
USD
|
|
2022-09-16 |
2022-09-16 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Large shareholder
|
484 496
+3.6%
10,32
4 999 999
USD
|
484 496
+3.6%
|
10,32
|
4 999 999
USD
|
|
2022-09-16 |
2022-09-14 |
A
Achat
|
Novo Holdings A/S
Large shareholder
|
484 496
+8.7%
10,32
4 999 999
USD
|
484 496
+8.7%
|
10,32
|
4 999 999
USD
|
|
2022-09-08 |
2022-09-06 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
2 351
-43.9%
10,99
25 842
USD
|
2 351
-43.9%
|
10,99
|
25 842
USD
|
|
2022-09-08 |
2022-09-06 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
2 379
-30.8%
10,83
25 756
USD
|
2 379
-30.8%
|
10,83
|
25 756
USD
|
|
2022-08-05 |
2022-08-03 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
9 232
-75.5%
9,31
85 921
USD
|
9 232
-75.5%
|
9,31
|
85 921
USD
|
|
2022-07-07 |
2022-07-06 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
1 046
-25.9%
8,54
8 928
USD
|
1 046
-25.9%
|
8,54
|
8 928
USD
|
|
2022-07-07 |
2022-07-05 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
8 186
-73.2%
8,35
68 329
USD
|
8 186
-73.2%
|
8,35
|
68 329
USD
|
|
2022-06-21 |
2022-06-21 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
31 078
-91.2%
7,29
226 695
USD
|
31 078
-91.2%
|
7,29
|
226 695
USD
|
|
2022-06-21 |
2022-06-17 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
22 127
-88.1%
6,62
146 434
USD
|
22 127
-88.1%
|
6,62
|
146 434
USD
|
|
2022-06-21 |
2022-06-16 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
14 722
-83.1%
6,17
90 805
USD
|
14 722
-83.1%
|
6,17
|
90 805
USD
|
|
2022-06-15 |
2022-06-15 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
18 075
-85.8%
6,11
110 445
USD
|
18 075
-85.8%
|
6,11
|
110 445
USD
|
|
2022-06-15 |
2022-06-15 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
585
-2.7%
6,11
3 575
USD
|
585
-2.7%
|
6,11
|
3 575
USD
|
|
2022-06-15 |
2022-06-14 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
3 628
-54.7%
6,02
21 855
USD
|
3 628
-54.7%
|
6,02
|
21 855
USD
|
|
2022-06-15 |
2022-06-13 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
4 093
-57.7%
6,01
24 582
USD
|
4 093
-57.7%
|
6,01
|
24 582
USD
|
|
2022-06-10 |
2022-06-10 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
7 125
-70.4%
6,05
43 120
USD
|
7 125
-70.4%
|
6,05
|
43 120
USD
|
|
2022-06-10 |
2022-06-09 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
7 615
-71.7%
6,49
49 397
USD
|
7 615
-71.7%
|
6,49
|
49 397
USD
|
|
2022-06-10 |
2022-06-08 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
12 566
-80.7%
6,63
83 362
USD
|
12 566
-80.7%
|
6,63
|
83 362
USD
|
|
2022-06-07 |
2022-06-07 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
17 150
-85.1%
6,61
113 276
USD
|
17 150
-85.1%
|
6,61
|
113 276
USD
|
|
2022-06-07 |
2022-06-07 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
973
-24.5%
6,61
6 427
USD
|
973
-24.5%
|
6,61
|
6 427
USD
|
|
2022-06-07 |
2022-06-06 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
13 934
-82.3%
6,03
84 085
USD
|
13 934
-82.3%
|
6,03
|
84 085
USD
|
|
2022-06-07 |
2022-06-03 |
V
Vente
|
MOORE JOHN R
General Counsel
Dirigeant
|
15 230
-83.5%
6,05
92 198
USD
|
15 230
-83.5%
|
6,05
|
92 198
USD
|
|
2022-05-20 |
2022-05-18 |
A
Achat
|
Thompson Peter A.
Administrateur non-exécutif
Large shareholder
|
138 000
+1.0%
7,21
994 980
USD
|
138 000
+1.0%
|
7,21
|
994 980
USD
|
|
2022-05-20 |
2022-05-18 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Large shareholder
|
138 000
+1.0%
7,21
994 980
USD
|
138 000
+1.0%
|
7,21
|
994 980
USD
|
|
2022-05-18 |
2022-05-16 |
VP
Vente planifiée
|
MOORE JOHN R
General Counsel
Dirigeant
|
10 800
-78.3%
7,42
80 146
USD
|
10 800
-78.3%
|
7,42
|
80 146
USD
|
|
2021-11-17 |
2021-11-15 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
38
-100.0%
19,61
745
USD
|
38
-100.0%
|
19,61
|
745
USD
|
|
2021-11-17 |
2021-11-15 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
441
-92.1%
19,07
8 410
USD
|
441
-92.1%
|
19,07
|
8 410
USD
|
|
2021-11-12 |
2021-11-12 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
8 562
-94.7%
19,51
167 074
USD
|
8 562
-94.7%
|
19,51
|
167 074
USD
|
|
2021-11-12 |
2021-11-11 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
3 681
-28.9%
20,43
75 195
USD
|
3 681
-28.9%
|
20,43
|
75 195
USD
|
|
2021-11-12 |
2021-11-11 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
15 595
-55.1%
19,82
309 043
USD
|
15 595
-55.1%
|
19,82
|
309 043
USD
|
|
2021-11-12 |
2021-11-10 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
580
-2.0%
20,21
11 723
USD
|
580
-2.0%
|
20,21
|
11 723
USD
|
|
2021-11-12 |
2021-11-10 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
11 746
-28.9%
19,70
231 447
USD
|
11 746
-28.9%
|
19,70
|
231 447
USD
|
|
2021-11-12 |
2021-11-09 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
12 712
-23.8%
20,30
258 031
USD
|
12 712
-23.8%
|
20,30
|
258 031
USD
|
|
2021-11-12 |
2021-11-09 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
16 864
-24.0%
19,94
336 275
USD
|
16 864
-24.0%
|
19,94
|
336 275
USD
|
|
2021-11-08 |
2021-11-08 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
9 017
-11.4%
20,16
181 824
USD
|
9 017
-11.4%
|
20,16
|
181 824
USD
|
|
2021-11-08 |
2021-11-05 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
13 036
-14.1%
19,62
255 783
USD
|
13 036
-14.1%
|
19,62
|
255 783
USD
|
|
2021-11-08 |
2021-11-05 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
6
-0.0%
20,70
124
USD
|
6
-0.0%
|
20,70
|
124
USD
|
|
2021-11-08 |
2021-11-04 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
7 392
-7.4%
19,76
146 092
USD
|
7 392
-7.4%
|
19,76
|
146 092
USD
|
|
2021-11-03 |
2021-11-03 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
1 119
-1.1%
19,42
21 726
USD
|
1 119
-1.1%
|
19,42
|
21 726
USD
|
|
2021-11-03 |
2021-11-03 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
4 243
-4.0%
18,84
79 944
USD
|
4 243
-4.0%
|
18,84
|
79 944
USD
|
|
2021-11-03 |
2021-11-03 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
20 822
-16.5%
17,98
374 425
USD
|
20 822
-16.5%
|
17,98
|
374 425
USD
|
|
2021-11-03 |
2021-11-02 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
17 519
-12.2%
17,43
305 360
USD
|
17 519
-12.2%
|
17,43
|
305 360
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
469
-0.3%
18,02
8 454
USD
|
469
-0.3%
|
18,02
|
8 454
USD
|
|
2021-10-18 |
2021-10-15 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
126
-0.1%
18,00
2 268
USD
|
126
-0.1%
|
18,00
|
2 268
USD
|
|
2021-10-18 |
2021-10-15 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
1 307
-0.9%
18,13
23 698
USD
|
1 307
-0.9%
|
18,13
|
23 698
USD
|
|
2021-10-18 |
2021-10-14 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
5 749
-3.8%
18,18
104 517
USD
|
5 749
-3.8%
|
18,18
|
104 517
USD
|
|
2021-10-13 |
2021-10-11 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
1 270
-0.8%
18,02
22 885
USD
|
1 270
-0.8%
|
18,02
|
22 885
USD
|
|
2021-10-08 |
2021-10-08 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
5 902
-3.7%
18,15
107 121
USD
|
5 902
-3.7%
|
18,15
|
107 121
USD
|
|
2021-10-08 |
2021-10-07 |
V
Vente
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
13 018
-7.6%
18,56
241 614
USD
|
13 018
-7.6%
|
18,56
|
241 614
USD
|
|
2021-10-08 |
2021-10-06 |
VP
Vente planifiée
|
Russell Alan J
Chief Scientific Officer
Administrateur exécutif
|
2 108
-1.2%
18,03
38 007
USD
|
2 108
-1.2%
|
18,03
|
38 007
USD
|
|